The DOI matches its Crossref record; 286 of the 287 references it cites were found in a registry or an index; none of the 98 sources its claims cite is checked for support yet.
Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128
Open accessAbstract
MicroRNAs, the non-coding single-stranded RNA of 19-25 nucleotides are emerging as robust players of gene regulation. Plethora of evidences support that the ability of microRNAs to regulate several genes of a pathway or even multiple cross talking pathways have significant impact on a complex regulatory network and ultimately the physiological processes and diseases. Brain being a complex organ with several cell types, expresses more distinct miRNAs than any other tissues. This review aims to discuss about the microRNAs in brain development, function and their dysfunction in brain tumors. We also provide a comprehensive summary of targets of brain specific and brain enriched miRNAs that contribute to the diversity and plasticity of the brain. In particular, we uncover recent findings on miRNA-128, a brain-enriched microRNA that is induced during neuronal differentiation and whose aberrant expression has been reported in several cancers. This review describes the wide spectrum of targets of miRNA-128 that have been identified till date with potential roles in apoptosis, angiogenesis, proliferation, cholesterol metabolism, self renewal, invasion and cancer progression and how this knowledge might be exploited for the development of future miRNA-128 based therapies for the treatment of cancer as well as metabolic diseases.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review summarizes brain microRNAs, with a focus on brain-enriched miRNA-128 in neuronal differentiation, brain tumors, apoptosis, angiogenesis, and cholesterol metabolism. It compiles validated targets and bioinformatic analyses suggesting conserved miRNA-128 targets and enriched signaling pathways relevant to cancer and metabolic disease.
Key findings
- The brain expresses more distinct miRNAs than any other vertebrate tissue; 70% of known miRNAs are expressed in the brain, though only a handful are brain-specific or brain-enriched. Sempere et al. identified 17 miRNAs expressed in mouse and human brain, including miR-128.
- miRNA-128 is transcribed by two genes: miRNA-128-1 in R3HDM1 on chromosome 2q21.3 and miRNA-128-2 in ARPP21 on chromosome 3p22.3. It is induced during neuronal differentiation and is downregulated in glioblastoma, medulloblastoma, and neuroblastoma, and deregulated in autism, prion-induced neurodegeneration, Huntington disease, Parkinson disease, and Alzheimer disease.
- Validated miRNA-128 targets/effects include Bmi-1, E2F3a, EGFR, PDGFRα, Reelin, DCX, SNAP25, SIRT1, Bax, and ABCA1/ABCG1/RXRα. Depending on cell type, miRNA-128 can be pro-apoptotic or anti-apoptotic, and it regulates proliferation, self-renewal, invasion, angiogenesis, and cholesterol homeostasis.
- Bioinformatic analysis identified 90 miRNA-128 targets conserved among 9 species. PANTHER and GeneCodis enrichment showed insulin/IGF-MAPK, TGF-beta, angiogenesis, PI3K, and Wnt pathways among the most enriched; insulin and chemokine signaling were enriched in both analyses (p < 0.05), and metabolic process was the highest-rated biological process by PANTHER.
Methods
- Literature review of brain microRNAs and miRNA-128, with tables summarizing brain-enriched and brain-specific miRNAs, their validated targets, functions, and disease associations.
- Bioinformatics: predicted miRNA-128 targets from TargetScan 5 for nine species (human, mouse, chimpanzee, rhesus, cow, chicken, frog, rat, opossum), filtered to 90 targets conserved across all nine species, then pathway enrichment using PANTHER and GeneCodis.
- No primary wet-lab experiments are reported in this review; it synthesizes prior studies, including the authors’ own published work.
Limitations
- The authors state that high-throughput target validation methods are lacking, many cellular functions and pathways affected by miRNA-128 remain undiscovered, and regulation of Wnt and chemokine signaling by miRNA-128 needs further validation.
- The authors state that their in vitro cholesterol results require in vivo validation, that the role of miRNA-128a in HIV-1 encephalopathy needs to be determined, and that it is not known whether miRNA-128 changes in cancer are a cause or effect of disease.
- Evident from the text: as a review, conclusions depend on cited studies; miRNA-128 shows context-dependent pro-apoptotic and anti-apoptotic roles and both up- and down-regulation across diseases, limiting simple therapeutic generalization.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
67 Sources not found · 10 Own result · 9 Own interpretation · 1 Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we also demonstrated that miRNA-128 augments the antitumor effects of compounds (Etoposide and Cisplatin).”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Pro-neural miRNA-128 as regulator of apoptosis
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“We provided the first evidence of miRNA-128-2 to be a new regulator of cholesterol homeostasis [277].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Insights into regulation of cholesterol metabolism by miRNA-128: a new key player in cholesterol related disorders
What the sources say
- Not matchedcites [277]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“metabolic process came out to be the highest rated biological process with maximum number of genes during PANTHER Analysis (Figure 5).”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Biological relevance of miRNA-128 as revealed by bioinformatic analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“insilico analysis of transcription factor binding sites of these two genes reveals almost similar pattern of transcription factors (unpublised data).”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Future directions/conclusions
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“over expression of miRNA-128 in HEK293T cells led to an increase in reactive oxygen species [57].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of miRNA-128 in cell motility, angiogenesis and senescence
What the sources say
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“miRNA-128 also regulates cholesterol metabolism and fatty acid biosynthesis pathways.”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Insights into regulation of cholesterol metabolism by miRNA-128: a new key player in cholesterol related disorders
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we discovered that 90 targets of miRNA-128 were conserved among 9 species (Human, Mouse, Chimpanzee, Rhesus, Cow, Chicken, Frog, Rat, Opossum)”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Biological relevance of miRNA-128 as revealed by bioinformatic analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“we recently observed that miRNA-128 overexpression induced apoptosis by down regulation of Bax and up regulation of p53 and Bak [57].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Pro-neural miRNA-128 as regulator of apoptosis
What the sources say
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“we observed that the Insulin signaling pathway and chemokine signaling pathway were the enriched categories (p-value < 0.05) in both PANTHER and GeneCodis analysis.”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Biological relevance of miRNA-128 as revealed by bioinformatic analysis
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade, TGF-beta signaling pathway, Angiogenesis, Insulin/IGF pathway-protein kinase B signaling cascade, PI3 kinase pathway, Wnt signaling pathway were found to be the most enriched biological pathways as revealed by the PANTHER analysis (Figure 4).”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Biological relevance of miRNA-128 as revealed by bioinformatic analysis
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 18
- Probably not a substantial claim. 18
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“miRNA-128 up-regulated cholesterol synthesis genes and down regulated fatty acid biosynthesis genes.”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Insights into regulation of cholesterol metabolism by miRNA-128: a new key player in cholesterol related disorders
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“we found that miRNA-128 induces apoptosis in wild type (WT) p53 as well as in mutant p53-expressing cells in a p53-dependent and -independent manner via induction of PUMA in MCF7, MDA-MB-231, HCT116 p53 +/+ and HCT116 p53 -/- cells respectively [264].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Pro-neural miRNA-128 as regulator of apoptosis
What the sources say
- Not matchedcites [264]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“Similar to miR-124, miRNA-128 is induced during brain development and in differentiating neuronal cells”
- Also stated in: § Abstract · plain
“In particular, we uncover recent findings on miRNA-128, a brain-enriched microRNA that is induced during neuronal differentiation and whose aberrant expression has been reported in several cancers.”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > MicroRNAs in brain development and function
What the sources say
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § Abstract · plain
In the paper
“Godlewski et al., reported that overexpression of miRNA-128 reduces glioma cell proliferation by downregulating Bmi-1 (B lymphoma mouse Moloney leukemia virus insertion region 1), decrease in histone methylation (H3K27me3) and Akt phosphorylation and up-regulation of p21CIP1 levels [60].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of pro-neural miRNA-128 in brain related disorders
What the sources say
- Not matchedcites [60]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“Papagiannakopoulos et al. recently showed that miRNA-128 represses growth and enhances neuronal differentiation of glioma-initiating neural stem cells (giNSCs) by downregulating oncogenic receptor tyrosine kinases (RTKs), epithelial growth factor receptor (EGFR) and platelet-derived growth factor receptor-α (PDGFRα) (Figure 2) [59].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of pro-neural miRNA-128 in brain related disorders
What the sources say
- Not matchedcites [59]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“Literature reveals that a single miRNA can target several mRNAs together, and a single mRNA can be targeted by different miRNAs in a concerted manner.”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction
What the sources say
- Not matchedcites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not matched
In the paper
“overexpression of miRNA-128 inhibited cellular proliferation through negatively regulating E2F3a, which is highly expressed in glioma and important for cell cycle progression (Figure 2) [58].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of pro-neural miRNA-128 in brain related disorders
What the sources say
- Not matchedcites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“leading to repressed NMD (Nonsense-mediated decay) and the consequent upregulation of batteries of mRNAs encoding proteins important for neuron differentiation and function [56].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > MicroRNAs in brain development and function
What the sources say
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“MiRNA-128-1 is embedded in the R3HDM1 (R3H domain containing 1) gene on chromosome 2q21.3”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of pro-neural miRNA-128 in brain related disorders
What the sources say
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
In the paper
“As Bmi-1 is also known to promote the stem cell renewal, a process that is important in glioma”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of pro-neural miRNA-128 in brain related disorders
What the sources say
- Not matchedcites [237]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“Literature reveals that 70% of known miRNAs are expressed in the brain [50].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > MicroRNAs in brain development and function
What the sources say
- Not matchedcites [50]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“There are a few reports which have talked about the involvement of miRNA-128 in TGF-β signaling [282] and PI3 kinase pathway [60].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Biological relevance of miRNA-128 as revealed by bioinformatic analysis
What the sources say
- Not matchedcites [282]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [60]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
In the paper
“Up regulation of miRNA-128 not only suppressed the colony formation ability and invasiveness of pituitary tumor cells but also suppressed pituitary GH3 tumor growth in xenografts via, Bmi-1.”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Expression of pro-neural miRNA-128 in cancers other than brain
What the sources say
- Not matchedcites [62]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“over expression of miRNA-128 attenuated invasion in prostate cancer cells while its knockdown induced invasion in benign prostate epithelial cells as revealed by matrigel invasion assay [258].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of miRNA-128 in cell motility, angiogenesis and senescence
What the sources say
- Not matchedcites [258]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“as well as in acute lymphoblastic leukemia (ALL) [244]”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Expression of pro-neural miRNA-128 in cancers other than brain
What the sources say
- Not matchedcites [244]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“is overexpressed in retinoblastoma and esophageal carcinoma and its expression is directly correlated with tumor aggressiveness [271,272].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of miRNA-128 in cell motility, angiogenesis and senescence
What the sources say
- Not matchedcites [271]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [272]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not matched
In the paper
“Yolanda’s group has shown that ectopic expression of miRNA-128 downregulated genes that induce apoptosis and upregulated genes implicated in cell survival [63].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Pro-neural miRNA-128 as regulator of apoptosis
What the sources say
- Not matchedcites [63]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These findings suggest that miRNA-128 reduces cell motility and invasiveness of tumor cells and thus prevents angiogenesis.”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of miRNA-128 in cell motility, angiogenesis and senescence
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Donzelli et al. observed that miRNA-128-2 expression in lung cancer cells inhibits apoptosis and confers increased resistance to cisplatin, doxorubicin and 5-Fluorouracyl treatment via E2F5 (Figure 2) [266].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Pro-neural miRNA-128 as regulator of apoptosis
What the sources say
- Not matchedcites [266]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not matched
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“Synaptogenesis; reduces neuroblastoma cell motility and invasiveness; suppressor of PRC activity; renders glioma stemlike cells less radioresistant; suppressor of the colony formation ability and invasiveness of pituitary tumor cells; suppressor of growth and mediates differentiation; regulates Nonsense-mediated decay; regulates apoptosis, inhibits proliferation and self-renewal,”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > MicroRNAs in brain development and function
What the sources say
- Not matchedcites [55]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [56]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [57]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [58]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [59]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [60]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [61]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [62]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [63]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [64]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
In the paper
“DCX is a microtubule-associated protein required for neuroblastic migration during cerebral cortex development [267]”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of miRNA-128 in cell motility, angiogenesis and senescence
What the sources say
- Not matchedcites [267]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“raise the possibility of exploiting miRNA-128 for therapeutic intervention and development of novel therapies.”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Future directions/conclusions
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
In the paper
“Reelin is a high-molecular-weight secreted glycoprotein, which is thought to play its role as a guide for migratory neurons [268].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of miRNA-128 in cell motility, angiogenesis and senescence
What the sources say
- Not matchedcites [268]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not matched
In the paper
“Monteys et al. have recently suggested dual regulation of miRNA-128-2 by both intronic (pol III) and host gene (Pol II) promoters in acute lymphoblastic leukemia [283].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Future directions/conclusions
What the sources say
- Not matchedcites [283]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“alterations in miRNA expression may play a critical role in the cancer initiation and progression [255,256].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Expression of pro-neural miRNA-128 in cancers other than brain
What the sources say
- Not matchedcites [255]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [256]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
In the paper
“MiRNA expression can be correlated with cancer type, stage, and other clinical variables which may be useful for the classification, diagnosis, or prognosis of some human malignancies [257].”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Expression of pro-neural miRNA-128 in cancers other than brain
What the sources say
- Not matchedcites [257]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
In the paper
“Alterations in susceptibility to apoptosis is a key factor for the survival of a malignant cell [261]”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Pro-neural miRNA-128 as regulator of apoptosis
What the sources say
- Not matchedcites [261]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
In the paper
“Reelin has been shown to be a positive marker for prostate carcinoma aggressiveness [270]”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of miRNA-128 in cell motility, angiogenesis and senescence
What the sources say
- Not matchedcites [270]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
None of the sources cited for this claim could be matched to a paper in Crossref, so there is nothing to check it against.
In the paper
“recent evidence indicates that miRNAs may function as tumor suppressors (by binding to oncogenes and suppressing them) or oncogenes (by binding to tumor suppressor genes and suppressing them)”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Expression of pro-neural miRNA-128 in cancers other than brain
What the sources say
- Not matchedcites [255]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not matchedcites [256]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The fact that miRNA-128 plays multiple roles - a pro-apoptotic molecule, a anti-apoptotic molecule as well as a regulator of cholesterol homeostasis”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Future directions/conclusions
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds. It may state two separate claims as one.
The paper relies on this without support.
miRNA-128 is the most abundant brain-enriched miRNA.
“before delving into specific example of miRNA-128, the most abundant brain-enriched miRNA”
The paper relies on this without support.
miRNA-128 has tissue-specific and developmental-specific expression patterns.
“Evidences in the literature reveal that miRNA-128 has tissue specific and developmental specific expression patterns.”
The paper relies on this without support.
Apart from brain, miRNA-128 is found in skeletal muscle and thymus and is highly expressed during neuronal differentiation.
“Apart from brain, miRNA-128 has also been found in the skeletal muscle and thymus and is highly expressed during neuronal differentiation.”
The paper relies on this without support.
miRNAs normally negatively regulate their transcript targets.
“miRNAs normally negatively regulate their transcript targets”
The paper relies on this without support.
Cancer occurs due to accumulation of several genomic alterations and is characterized by unrestricted proliferation, invasion, and metastasis.
“Cancer occurs due to accumulation of several genomic alterations and is characterized by unrestricted proliferation, invasion, and metastasis.”
The paper relies on this without support.
MiRNA-128 is encoded by two distinct genes, R3HDM1 and ARPP21.
“MiRNA-128 is encoded by two distinct genes, viz., R3HDM1 and ARPP21.”
The paper relies on this without support.
The overall cellular functions and pathways affected by miRNA-128 remain undiscovered due to lack of high throughput target validation methods.
“The overall cellular functions and pathways affected by this miRNA remains still undiscovered due to lack of high throughput target validation methods.”
The paper relies on this without support.
Ability to migrate and disseminate to distal sites is one of the key characteristics of tumor cells, which is also responsible for the relative aggressiveness of the tumor.
“Ability to migrate and eventually disseminate to distal sites is one of the key characteristic of tumor cells, which is also responsible for the relative aggressiveness of the tumor.”
The paper relies on this without support.
Aberrant regulation of cholesterol homeostasis is associated with obesity as well as multiple types of cancer.
“Aberrant regulation of cholesterol homeostasis is associated with obesity as well as multiple types of cancer.”
The paper relies on this without support.
DCX expression is detectable in some tumors of the nervous system, such as GBM and neuroblastoma.
“DCX expression is also detectable in some tumors of the nervous system, such as GBM and neuroblastoma.”
The paper relies on this without support.
Overexpression of miRNA-128 leads to increased methylation of histone 3 lysine 9 (H3K9me2).
“Observation by Venkatraman’s group of increased methylation of histone 3 lysine 9 (H3K9me2) (a mark of repressed gene expression mediated by the Bmi-1 polycomb repressor complex) after overexpression of miRNA-128”
The paper relies on this without support.
Overexpression of miRNA-128a in medulloblastoma alters the intracellular redox state of the tumor cells.
“overexpression of miRNA-128a in medulloblastoma alters the intracellular redox state of the tumor cells.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of pro-neural miRNA-128 in brain related disorders
“| hsa-miRNA-128 | Glioma | d | [58] | 2008 |”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > References
“58. Zhang Y Chao T Li R Liu W Chen Y Yan X Gong Y Yin B Qiang B Zhao J Yuan J Peng X MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a J Mol Med (Berl) 2009 87 43 51”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > Role of pro-neural miRNA-128 in brain related disorders
“| hsa-miRNA-128 | Huntington’s disease | d | [241] | 2010 |”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > References
“241. Lee ST Chu K Im WS Yoon HJ Im JY Park JE Park KH Jung KH Lee SK Kim M Roh JK Altered microRNA regulation in Huntington’s disease models Exp Neurol 2011 227 172 179”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction
“MicroRNAs (miRNAs) interfere with target gene expression by binding to the 3′ UTRs of their target mRNAs and act primarily at the level of translation.”
§ Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 > Introduction > MiRNA biogenesis and mechanism of action
“However, it is now believed that miRNA regulate gene expression in majority of cases by mRNA decay rather than translational repression [47].”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Chen Z Li D Cheng Q Ma Z Jiang B Peng R Chen R Cao Y Wan X MicroRNA-203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2 Mol Med Rep 2014 9 503 508 24270883”
Cited work 10.3892/mmr.2013.1814 · retracted 2023-12-27 · notice 10.3892/mmr.2023.13154 · this paper published 2014
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“10.1371/journal.pone.0055008”
Cited work 10.1371/journal.pone.0055008 · retracted 2020-01-23 · notice 10.1371/journal.pone.0228340 · this paper published 2014
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“10.1016/j.stem.2007.04.001”
Cited work 10.1016/j.stem.2007.04.001 · retracted 2023-06-01 · notice 10.1016/j.stem.2023.05.009 · this paper published 2014
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
Cited work 10.1111/cas.12351 · retracted 2024-07-22 · notice 10.1111/cas.16269 · this paper published 2014
Citations
Cites
4 retracted
Fasano, C. A., Dimos, J. T., Ivanova, N. B., Lowry, N. A., Lemischka, I. R., & Temple, S. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.04.001 · Cited by 308
RetractedYang, T., Lu, X., Wu, T., Ding, D.-D., Zhao, Z., Chen, G., Xie, X., Li, B., Wei, Y., Guo, L., et al. (2014) · Cancer Science · doi:10.1111/cas.12351 · Cited by 130
RetractedMiR-30a-5p Antisense Oligonucleotide Suppresses Glioma Cell Growth by Targeting SEPT7
Jia, Z., Wang, K., Wang, G., Zhang, A., & Pu, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055008 · Cited by 68
RetractedChen, Z., LI, D., Cheng, Q., Ma, Z., Jiang, B., Peng, R., Chen, R., Cao, Y., & Wan, X. H. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1814 · Cited by 56
RetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
The 2007 WHO Classification of Tumours of the Central Nervous System
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0243-4 · Cited by 15,675
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 9,051
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Cited by
Sorted by citations
The potential of endurance exercise-derived exosomes to treat metabolic diseases
Safdar, A., Saleem, A., & Tarnopolsky, M. A. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.76 · Cited by 463
A rigorous method to enrich for exosomes from brain tissue
Vella, L. J., Scicluna, B. J., Cheng, L., Bawden, E., Masters, C. L., Ang, C., Williamson, N. A., McLean, C., Barnham, K. J., & Hill, A. F. (2017) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2017.1348885 · Cited by 321
Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
Kumar, S., & Reddy, P. H. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.06.001 · Cited by 292
Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders
van den Berg, M. M. J., Krauskopf, J., Ramaekers, J. G., Kleinjans, J. C. S., Prickaerts, J., & Briedé, J. J. (2019) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2019.101732 · Cited by 260
Exosomes as Mediators of the Systemic Adaptations to Endurance Exercise
Safdar, A., & Tarnopolsky, M. A. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029827 · Cited by 203
Vieira, M. S., Santos, A. K., Vasconcellos, R., Goulart, V. A. M., Parreira, R. C., Kihara, A. H., Ulrich, H., & Resende, R. R. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.08.002 · Cited by 192
A Literature Review of Traumatic Brain Injury Biomarkers
Ghaith, H. S., Nawar, A. A., Gabra, M. D., Essam, M., Nafady, M. H., Bahbah, E. I., Ebada, M. A., Ashraf, G. M., Negida, A., & Barreto, G. E. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02822-6 · Cited by 196
MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways
El Fatimy, R., Li, S., Chen, Z., Mushannen, T., Gongala, S., Wei, Z., Balu, D. T., Rabinovsky, R., Cantlon, A., Elkhal, A., et al. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1880-5 · Cited by 161
MicroRNAs in Neurodegenerative Diseases
(2017) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2017.04.002 · Cited by 168
Resveratrol as a Natural Autophagy Regulator for Prevention and Treatment of Alzheimer’s Disease
Kou, X., & Chen, N. (2017) · Nutrients · doi:10.3390/nu9090927 · Cited by 165
Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration
Huang, W., Feng, Y., Liang, J., Yu, H., Wang, C., Wang, B., Wang, M., Jiang, L., Meng, W., Cai, W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03019-z · Cited by 139
Xitong, D., & Xiaorong, Z. (2015) · Gene · doi:10.1016/j.gene.2015.08.067 · Cited by 148
Farina, F. M., Hall, I. F., Serio, S., Zani, S., Climent, M., Salvarani, N., Carullo, P., Civilini, E., Condorelli, G., Elia, L., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316489 · Cited by 144
A Review of MicroRNA Biomarkers in Traumatic Brain Injury
Atif, H., & Hicks, S. D. (2019) · Journal of Experimental Neuroscience · doi:10.1177/1179069519832286 · Cited by 137
Microglia-derived extracellular vesicles in Alzheimer’s Disease: A double-edged sword
Trotta, T., Antonietta Panaro, M., Cianciulli, A., Mori, G., Di Benedetto, A., & Porro, C. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.12.020 · Cited by 126
Exosomes: Nanoparticulate tools for RNA interference and drug delivery
Shahabipour, F., Barati, N., Johnston, T. P., Derosa, G., Maffioli, P., & Sahebkar, A. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25766 · Cited by 117
Yan, W., Wu, Q., Yao, W., Li, Y., Liu, Y., Yuan, J., Han, R., Yang, J., Ji, X., & Ni, C. (2017) · Scientific Reports · doi:10.1038/s41598-017-11904-8 · Cited by 113
A Comparative Review of microRNA Expression Patterns in Autism Spectrum Disorder
Hicks, S. D., & Middleton, F. A. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00176 · Cited by 103
MicroRNAs Dysregulation and Mitochondrial Dysfunction in Neurodegenerative Diseases
Catanesi, M., d’Angelo, M., Tupone, M. G., Benedetti, E., Giordano, A., Castelli, V., & Cimini, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21175986 · Cited by 101
Genome-wide differential expression of synaptic long noncoding RNAs in autism spectrum disorder
Wang, Y., Zhao, X., Ju, W., Flory, M. J., Zhong, J. L., Jiang, S., Wang, P., Dong, X., Tao, X., Chen, Q., et al. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.144 · Cited by 99
Current Understanding of the Neural Stem Cell Niches
Llorente, V., Velarde, P., Desco, M., & Gómez‐Gaviro, M. V. (2022) · Cells · doi:10.3390/cells11193002 · Cited by 106
Altered Circulating miRNA Expression Profile in Pregestational and Gestational Obesity
Carreras‐Badosa, G., Bonmatí, A., Ortega, F. J., Mercader, J. M., Guindo-Martínez, M., Torrents, D., Prats‐Puig, A., Martínez‐Calcerrada, J., Platero-Gutierrez, E., de Zegher, F., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2872 · Cited by 93
Circulating microRNAs as biomarkers in progressive multiple sclerosis
Vistbakka, J., Elovaara, I., Lehtimäki, T. J., & Hagman, S. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516651141 · Cited by 90
MicroRNAs, Aging, Cellular Senescence, and Alzheimer's Disease
Reddy, P. H., Williams, J. M., Smith, F., Bhatti, J. S., Kumar, S., Vijayan, M., Kandimalla, R. J. L., Kuruva, C. S., Wang, R., Mańczak, M., et al. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.009 · Cited by 89
Doroszkiewicz, J., Groblewska, M., & Mroczko, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094610 · Cited by 88
Luo, M., Lee, L. K. C., Peng, B., Choi, C. H. J., Tong, W. Y., & Voelcker, N. H. (2022) · Advanced Science · doi:10.1002/advs.202201740 · Cited by 85
Elevation of brain-enriched miRNAs in cerebrospinal fluid of patients with acute ischemic stroke
Sørensen, S. S., Nygaard, A., Carlsen, A. L., Heegaard, N. H. H., Bak, M., & Christensen, T. (2017) · Biomarker Research · doi:10.1186/s40364-017-0104-9 · Cited by 78
Zhang, W., Kim, P. J., Chen, Z., Lokman, H., Qiu, L., Zhang, K., Rozen, S. G., Tan, E. K., Je, H. S., & Zeng, L. (2016) · eLife · doi:10.7554/elife.11324 · Cited by 71
Lecca, D., Marangon, D., Coppolino, G., Méndez, A. M., Finardi, A., Costa, G. D., Martinelli, V., Furlan, R., & Abbracchio, M. P. (2016) · Scientific Reports · doi:10.1038/srep34503 · Cited by 76
ENĂTESCU, V. R., Papavă, I., Enătescu, I., Antonescu, M., Anghel, A., Șeclăman, E. P., Sîrbu, I. O., & Marian, C. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.5.549 · Cited by 74
MicroRNA-Based Drugs for Brain Tumors
Anthiya, S., Griveau, A., Loussouarn, C., Baril, P., Garnett, M. C., Issartel, J., & Garcion, E. (2018) · Trends in cancer · doi:10.1016/j.trecan.2017.12.008 · Cited by 72
MicroRNAs: Not “Fine-Tuners” but Key Regulators of Neuronal Development and Function
Davis, G. M., Haas, M., & Pocock, R. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00245 · Cited by 69
The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity
Koenig, E. M., Fisher, C. D., Bernard, H., Wolenski, F. S., Gerrein, J., Carsillo, M., Gallacher, M., Tse, A., Peters, R., Smith, A. T., et al. (2016) · BMC Genomics · doi:10.1186/s12864-016-2958-x · Cited by 69
RVG29-modified microRNA-loaded nanoparticles improve ischemic brain injury by nasal delivery
Hao, R., Sun, B., Yang, L., Ma, C., & Li, S. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1760960 · Cited by 68
Geng, L., Zhang, T., Liu, W., & Chen, Y. (2018) · Yonsei Medical Journal · doi:10.3349/ymj.2018.59.9.1096 · Cited by 65
MiRNA-137-mediated modulation of mitochondrial dynamics regulates human neural stem cell fate
Channakkar, A. S., Singh, T., PATTNAIK, B. R., Gupta, K., Seth, P., & Adlakha, Y. K. (2020) · Stem Cells · doi:10.1002/stem.3155 · Cited by 62
Self-citationBrickler, T., Hazy, A., Correa, F. G., Dai, R., Kowalski, E., Dickerson, R., Chen, J., Wang, X., Morton, P. D., Whittington, A. R., et al. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0914-18.2018 · Cited by 61
Żurawek, D., & Turecki, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111312 · Cited by 62
Reddy, D. S., & Abeygunaratne, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911734 · Cited by 58
The long-term impact of adverse caregiving environments on epigenetic modifications and telomeres
Blaze, J., Asok, A., & Roth, T. L. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00079 · Cited by 61
Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients
Vistbakka, J., Sumelahti, M., Lehtimäki, T. J., Elovaara, I., & Hagman, S. (2018) · Acta Neurologica Scandinavica · doi:10.1111/ane.12921 · Cited by 57
Li, R., Yin, F., Guo, Y., Zhao, K., Ruan, Q., & Qi, Y.-M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.05.122 · Cited by 56
RetractedRegulatory function of microRNAs in microglia
Brites, D. M. T. O. (2020) · Glia · doi:10.1002/glia.23846 · Cited by 59
Zhao, C., Guo, R., Guan, F., Ma, S., Li, M., Wu, J., Liu, X., Li, H., & Yang, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-65331-3 · Cited by 51
Lu, Y., Xu, X., Dong, R., Sun, L., Chen, L., Zhang, Z., & Peng, M. (2019) · Cytokine · doi:10.1016/j.cyto.2019.04.005 · Cited by 54
Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network
Lou, W., Ding, B., Xu, L., & Fan, W. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00066 · Cited by 53
Zhu, L., Lin, M., Ma, J., Liu, W., Gao, L., Wei, S., Xue, Y., & Shang, X. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14214 · Cited by 52
Paramasivam, P., Poongothai, S., Shanthirani, C. S., Anjana, R. M., Mohan, V., & Balasubramanyam, M. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01486-9 · Cited by 55
The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy
Budi, H. S., Younus, L. A., Lafta, M. H., Parveen, S., Mohammad, H. J., Al‐qaim, Z. H., Jawad, M. A., Romero‐Parra, R. M., Mustafa, Y. F., Alhachami, F. R., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1067974 · Cited by 51
Identification of organ tissue types and skin from forensic samples by microRNA expression analysis
Sauer, E., Extra, A., Cachée, P., & Courts, C. (2017) · Forensic Science International Genetics · doi:10.1016/j.fsigen.2017.02.002 · Cited by 50
MicroRNA Cross-Involvement in Autism Spectrum Disorders and Atopic Dermatitis: A Literature Review
Tonacci, A., Bagnato, G., Pandolfo, G., Billeci, L., Sansone, F., Conte, R., & Gangemi, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8010088 · Cited by 51
Anabolic Androgenic Steroids: Searching New Molecular Biomarkers
Sessa, F., Salerno, M., Mizio, G. D., Bertozzi, G., Messina, G., Tomaiuolo, B., Pisanelli, D., Maglietta, F., Ricci, P., & Pomara, C. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01321 · Cited by 49
Genome annotation for clinical genomic diagnostics: strengths and weaknesses
Steward, C. A., Parker, A. P. J., Minassian, B. A., Sisodiya, S. M., Frankish, A., & Harrow, J. (2017) · Genome Medicine · doi:10.1186/s13073-017-0441-1 · Cited by 51
Karaboue, M. A. A., Ministeri, F., Sessa, F., Nannola, C., Chisari, M. G., Cocimano, G., Mauro, L. D., Salerno, M., & Esposito, M. (2024) · Healthcare · doi:10.3390/healthcare12222266 · Cited by 47
Sadakierska−Chudy, A., Frankowska, M., Miszkiel, J., Wydra, K., Jastrzębska, J., & Filip, M. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9817-2 · Cited by 46
The expanding horizon of MicroRNAs in cellular reprogramming
Adlakha, Y. K., & Seth, P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.11.003 · Cited by 47
Self-citationChen, G.-H., Xu, C., Zhang, J., Li, Q., Cui, H., Li, X., Chang, L., Tang, R., Xu, J., Tian, X., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00775 · Cited by 44
Posttranscriptional Regulation of Insulin Resistance: Implications for Metabolic Diseases
Pérez-García, A., Torrecilla-Parra, M., Frutos, M. F.-D., Martín-Martín, Y., Pardo, V., & Ramírez, C. M. (2022) · Biomolecules · doi:10.3390/biom12020208 · Cited by 45
MicroRNA‑124: an emerging therapeutic target in central nervous system disorders
Zhang, W.-H., Jiang, L., Li, M., & Liu, J. (2023) · Experimental Brain Research · doi:10.1007/s00221-022-06524-2 · Cited by 43
Su, X. W., Chan, A. H. Y., Lü, G., Lin, M., Sze, J., Zhou, J. Y., Poon, W. S., Liu, Q., Zheng, V. Z. Y., & Wong, G. K. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144724 · Cited by 42
The Diagnostic Value of Circulating Brain-specific MicroRNAs for Ischemic Stroke
Yang, Z., Li, T., Zhang, Z., Ren, K., Zheng, Z., Peng, J., & Luo, X. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5925 · Cited by 42
Role of microRNAs in the pathophysiology of addiction
Gowen, A. M., Odegaard, K. E., Hernandez, J. B., Chand, S., Koul, S., Pendyala, G., & Yelamanchili, S. V. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1637 · Cited by 40
Ceylan, H. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01893-9 · Cited by 40
Huang, Z., Weng, Y. Z., Shen, Q., Zhao, Y., Luo, T., Xiao, Y., Yang, G., & Jin, Y. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.122275 · Cited by 39
MiRNAs as major players in brain health and disease: current knowledge and future perspectives
Kapplingattu, S. V., Bhattacharya, S., & Adlakha, Y. K. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02283-x · Cited by 44
Self-citationAlsharafi, W. A., Xiao, B., & Li, J. (2016) · Epilepsia · doi:10.1111/epi.13568 · Cited by 39
Liu, R., Zhang, Q., Shen, L., Chen, S., He, J., Wang, D., Wang, Q., Qi, Z., Zhou, M., & Wang, Z. (2020) · Cell Biology and Toxicology · doi:10.1007/s10565-020-09524-6 · Cited by 39
The promising role of miR-296 in human cancer
Zhu, L., Deng, H., Hu, J., Huang, S., Xiong, J., & Deng, J. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.09.026 · Cited by 37
Mao, G., Ren, P., Wang, G., Yan, F., & Zhang, Y. (2016) · Journal of Molecular Neuroscience · doi:10.1007/s12031-016-0871-z · Cited by 37
Species-Specific miRNAs in Human Brain Development and Disease
Prodromidou, K., & Matsas, R. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00559 · Cited by 38
LncRNA FTX Promotes Colorectal Cancer Cells Migration and Invasion by miRNA-590-5p/RBPJ Axis
Chen, G., Liao, Z., Liu, J., Li, F., Huang, D., & Zhou, Y. (2021) · Biochemical Genetics · doi:10.1007/s10528-020-10017-8 · Cited by 34
Deng, M., Zhang, Q., Wu, Z., Ma, T., He, A., Zhang, T., Ke, X., Yu, Q., Han, Y., & Lu, Y. (2020) · Aging Cell · doi:10.1111/acel.13144 · Cited by 34
Wang, W.-Y., & Lu, W. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s262873 · Cited by 33
Iris Garcia-martinez, A., Sánchez‐Mora, C., Pagerols, M., Vanesa Richarte, B., Montse Corrales, F., Fadeuilhe, C., Cormand, B., Casas, M., Ramos‐Quiroga, J. A., & Marta Ribasés, A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.151 · Cited by 33
MicroRNA-100 suppresses human gastric cancer cell proliferation by targeting CXCR7
Cao, Y., Song, J., Ge, J., Song, Z., Chen, J., & Wu, C. (2017) · Oncology Letters · doi:10.3892/ol.2017.7305 · Cited by 32
Blood biomarkers for assessment of mild traumatic brain injury and chronic traumatic encephalopathy
Hiskens, M. I., Schneiders, A. G., Angoa-Pérez, M., Vella, R. K., & Fenning, A. S. (2020) · Biomarkers · doi:10.1080/1354750x.2020.1735521 · Cited by 32
Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis
Ogonowski, N. S., Salcidua, S., León, T., Chamorro-Veloso, N., Valls, C., Avalos, C., Bisquertt, A., Rentería, M. E., Orellana, P., & Duran-Aniotz, C. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.807764 · Cited by 35
Samy, A. M., Kandeil, M. A., Sabry, D., Abdel‐Ghany, A. A., & Mahmoud, M. O. (2024) · Archiv der Pharmazie · doi:10.1002/ardp.202300631 · Cited by 30
Sui, M., Zheng, Q., Wu, H., Zhu, L., Ling, Y., Wang, L., Fang, F., Liu, Y., Zhang, Z., Chu, M., et al. (2019) · Animal Biotechnology · doi:10.1080/10495398.2019.1622555 · Cited by 30
An Emerging Role of miRNAs in Neurodegenerative Diseases: Mechanisms and Perspectives on miR146a
Kaidery, N. A., Ahuja, M., Sharma, S. M., & Thomas, B. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8256 · Cited by 30
Zhou, X., Hong, Y., Liu, Y., Wang, L., Liu, X., Li, Y., Yuan, H., & Hu, F. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02190-w · Cited by 28
Bazrgar, M., Khodabakhsh, P., Mohagheghi, F., Prudencio, M., & Ahmadiani, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104729 · Cited by 29
Artificial Intelligence and the detection of pediatric concussion using epigenomic analysis
Bahado-Singh, R. O., Vishweswaraiah, S., Er, A., Aydas, B., Türkoğlu, O., Taşkın, B. D., Duman, M., Yılmaz, D., & Radhakrishna, U. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146510 · Cited by 27
Wallach, T., Wetzel, M., Dembny, P., Staszewski, O., Krüger, C., Buonfiglioli, A., Prinz, M., & Lehnardt, S. (2020) · Cells · doi:10.3390/cells9010186 · Cited by 26
RNA-Seq Reveals miRNA Role Shifts in Seven Stages of Skeletal Muscles in Goat Fetuses and Kids
Ling, Y., Zheng, Q., Jing, J., Sui, M., Zhu, L., Li, Y., Zhang, Y., Liu, Y., Fang, F., & Zhang, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00684 · Cited by 26
Heterogeneity in major depressive disorder: The need for biomarker-based personalized treatments
Suseelan, S., & Pinna, G. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.09.001 · Cited by 28
Liu, P., Han, Z., Ma, Q., Liu, T., Wang, R., Tao, Z., Li, G., Li, F., Zhang, S., Li, L., et al. (2019) · Cell Transplantation · doi:10.1177/0963689719846848 · Cited by 23
Anitha, A., & Thanseem, I. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_5 · Cited by 25
The Role of Human Herpesvirus 6 Infection in Alzheimer’s Disease Pathogenicity—A Theoretical Mosaic
Romanescu, C., Schreiner, T. G., & Mukovozov, I. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113061 · Cited by 24
Non-Coding RNAs in Glioma Microenvironment and Angiogenesis
Li, D., Zhang, Z., Xia, C., Niu, C., & Zhou, W. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.763610 · Cited by 24
Kramarz, B., Huntley, R. P., Rodríguez-López, M., Roncaglia, P., Saverimuttu, S. C. C., Parkinson, H., Bandopadhyay, R., Martin, M. J., Orchard, S. E., Hooper, N. M., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200207 · Cited by 22
Age-related epigenetic regulation in the brain and its role in neuronal diseases
Kim‐Ha, J., & Kim, Y.-J. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.12.184 · Cited by 22
New insights into the regulatory roles of microRNAs in adult neurogenesis
Esteves, M., Serra-Almeida, C., Saraiva, C., & Bernardino, L. I. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.11.003 · Cited by 23
Molecular Dysregulation in Autism Spectrum Disorder
Gill, P. S., Clothier, J. L., Veerapandiyan, A., Dweep, H., Porter-Gill, P. A., & Schaefer, G. B. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11090848 · Cited by 22
The potential of exosomes as theragnostics in various clinical situations
Kang, J.-S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816053-4.00020-1 · Cited by 21
Review of bioinformatics in Azheimer's Disease Research
He, S., Dou, L., Li, X., & Zhang, Y. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105269 · Cited by 21
Advances of circRNA-miRNA-mRNA regulatory network in cerebral ischemia/reperfusion injury
Li, Y., Chen, W., Xiang, J., Deng, Q., Hu, Y., & Li, J. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113302 · Cited by 21
Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression
Bright, U., & Akirav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032052 · Cited by 21
Gadd45α modulates aversive learning through post‐transcriptional regulation of memory‐related mRNAs
Rey, A. A., Karaulanov, E., Sharopov, S., Arab, K., Schäfer, A., Gierl, M. S., Guggenhuber, S., Brandes, C., Pennella, L., Gruhn, W. H., et al. (2019) · EMBO Reports · doi:10.15252/embr.201846022 · Cited by 20
LncRNA MIR4435‑2HG inhibits the progression of osteoarthritis through miR‑510‑3p sponging
Liu, Y., Yang, Y., Ding, L., Jia, Y., & Ji, Y. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.8841 · Cited by 20
Metadata
- Authors
- Adlakha, Y. K., & Saini, N.
- Affiliations
- Institute of Genomics and Integrative Biology (IN)
- Corresponding author
- Saini, Neeru
- Venue
- Molecular Cancer
- Published
- 2014
- Volume
- 13
- Issue
- 1
- Pages
- 33
- ISSN
- 1476-4598 (ISSN-L)
- PMC
- PMC3936914
- OpenAlex
- W2151668353
- Semantic Scholar
- 5e2e0380167b8a7d1673392477a8315e67cd3687
- Cited by
- 213
- References
- 287
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 14 · 2023: 23 · 2022: 23 · 2021: 13 · 2020: 31 · 2019: 20 · 2018: 14 · 2017: 23 · 2016: 21 · 2015: 9 · 2014: 1
- FWCI
- 1.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Cancer (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Council of Scientific and Industrial Research, India (BSC 0123)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
- Keywords
- microRNA, brain development, brain tumors, neuronal differentiation, miRNA target genes, apoptosis, angiogenesis, tumor progression, cholesterol metabolism, self-renewal, tumor invasion, miRNA-based therapy, metabolic disorders
- MeSH terms
- Animals, Brain, Gene Expression Regulation, Humans, Neoplasms, Apoptosis, MicroRNAs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
